These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12169208)

  • 21. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.
    Taigen T; De Windt LJ; Lim HW; Molkentin JD
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1196-201. PubMed ID: 10655507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.
    Zobel C; Kassiri Z; Nguyen TT; Meng Y; Backx PH
    Circulation; 2002 Oct; 106(18):2385-91. PubMed ID: 12403671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcineurin and beyond: cardiac hypertrophic signaling.
    Molkentin JD
    Circ Res; 2000 Oct; 87(9):731-8. PubMed ID: 11055975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
    Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
    Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
    Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning and characterization of a novel muscle adenylosuccinate synthetase, AdSSL1, from human bone marrow stromal cells.
    Sun H; Li N; Wang X; Chen T; Shi L; Zhang L; Wang J; Wan T; Cao X
    Mol Cell Biochem; 2005 Jan; 269(1-2):85-94. PubMed ID: 15786719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcineurin in human heart hypertrophy.
    Ritter O; Hack S; Schuh K; Röthlein N; Perrot A; Osterziel KJ; Schulte HD; Neyses L
    Circulation; 2002 May; 105(19):2265-9. PubMed ID: 12010908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway.
    Rana OR; Saygili E; Meyer C; Gemein C; Krüttgen A; Andrzejewski MG; Ludwig A; Schotten U; Schwinger RH; Weber C; Weis J; Mischke K; Rassaf T; Kelm M; Schauerte P
    J Mol Cell Cardiol; 2009 Apr; 46(4):568-78. PubMed ID: 19150448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.
    De Windt LJ; Lim HW; Taigen T; Wencker D; Condorelli G; Dorn GW; Kitsis RN; Molkentin JD
    Circ Res; 2000 Feb; 86(3):255-63. PubMed ID: 10679475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes.
    Suzuki E; Nishimatsu H; Satonaka H; Walsh K; Goto A; Omata M; Fujita T; Nagai R; Hirata Y
    Circ Res; 2002 May; 90(9):1004-11. PubMed ID: 12016267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.
    Pu WT; Ma Q; Izumo S
    Circ Res; 2003 Apr; 92(7):725-31. PubMed ID: 12663489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
    Wilkins BJ; Molkentin JD
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
    Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
    Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NFAT-related protein NFATL1 (TonEBP/NFAT5) is induced upon T cell activation in a calcineurin-dependent manner.
    Trama J; Lu Q; Hawley RG; Ho SN
    J Immunol; 2000 Nov; 165(9):4884-94. PubMed ID: 11046013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
    Fiedler B; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II and norepinephrine activate specific calcineurin-dependent NFAT transcription factor isoforms in cardiomyocytes.
    Lunde IG; Kvaløy H; Austbø B; Christensen G; Carlson CR
    J Appl Physiol (1985); 2011 Nov; 111(5):1278-89. PubMed ID: 21474694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.